Prostate Clinic London

Prostate Cancer Screening Clinic

Get in Touch

    Prostate Cancer Screening Clinic

    Get in Touch

      Prostate Cancer Screening in London

      With Professor Prasanna Sooriakumaran, a world-leading prostate cancer specialist

      Concerns about prostate cancer can arise in different ways, whether due to a raised PSA level, new symptoms, or a desire for reassurance. At this stage, it is important to have clear, specialist guidance to understand what your results may mean and whether further investigation is required.
       
      Prostate cancer screening is not based on a single test, but on a structured and considered assessment of your individual risk. This includes interpreting PSA levels in the context of your age, medical history, symptoms, and other relevant factors, helping to avoid unnecessary investigations while ensuring that important findings are identified.
       
      Professor Prasanna Sooriakumaran provides expert prostate cancer screening, offering a precise and evidence-based approach to assessing prostate health. His focus is on delivering clarity, reducing uncertainty, and guiding appropriate next steps with confidence.

      Professor Prasanna Sooriakumaran
      MA (Oxon) BMedSci (Hons) BMBS (Hons) PGCertMedLaw ADCertClinInv (Cornell)
      FRCS (Urol) FEBU USMLE PhD

      Prostate Cancer Screening with Professor Prasanna Sooriakumaran

      Helping men understand when PSA testing and prostate cancer screening may be appropriate.

      Testimonials

      Professor Prasanna Sooriakumaran

      Book a Consultation

      Arrange a consultation with Professor Prasanna Sooriakumaran for clear, specialist guidance on your diagnosis, results, or treatment options.

      Book a Consultation

      Arrange a consultation with Professor Prasanna Sooriakumaran for clear, specialist guidance on your diagnosis, results, or treatment options.

      Excellent Google Reviews

      What Is Prostate Cancer Screening?

      Prostate cancer screening involves assessing the likelihood of prostate cancer in men who may or may not have symptoms. The aim is to identify potential concerns at an early stage and determine whether further investigation is required.

      Screening is not based on a single test, but on a structured evaluation of your individual risk. This typically includes a combination of clinical assessment, PSA blood testing, and imaging where appropriate.

      Results are interpreted in the context of your age, medical history, symptoms, and other relevant factors. This allows for a more accurate and individualised understanding of prostate health, helping to avoid unnecessary investigations while ensuring that significant findings are identified and managed appropriately.

      Fees and Pricing

      Understanding the costs of your assessment is an important part of planning your care. The following provides a guide to consultation fees associated with prostate cancer screening.

      Consultation Fees

      Initial Consultation

      £325

      A detailed consultation to assess your prostate health, review any PSA results or concerns, and determine whether screening or further investigation is appropriate. Appointments are available in person in London or remotely via video or telephone.

      Follow-Up Consultation

      £225

      Follow-up appointments are available to review test results, including PSA or imaging findings, and to provide clear guidance on any next steps or further investigation if required.

      Finance and Insurance

      At Prostate Clinic London, we aim to ensure specialist prostate cancer care is both transparent and accessible. A range of payment options is available, and most major private medical insurers are accepted, with guidance provided to help you understand costs, coverage, and the options available to you. The focus is on ensuring the process is clear and supportive, so you can concentrate on your health and making informed decisions about your care.

      Recognised Internationally for Excellence in Prostate Cancer Care

      Professor Prasanna Sooriakumaran has received over 30 international awards recognising his contribution to urology and prostate cancer care, including a National Clinical Impact Award for excellence beyond standard clinical practice.

      He is the only urologist worldwide to hold Visiting Professorships at both the University of Oxford and the All-India Institute of Medical Sciences, and has been named one of London’s most influential doctors. His work continues to shape modern approaches to prostate cancer surgery.

      Ranked Among the UK’s Top 10 Prostate Cancer Surgeons

      Experience plays a critical role in prostate cancer treatment, particularly when it comes to achieving the best possible outcomes. Surgical technique and specialist expertise can have a meaningful impact on cancer control, as well as functional outcomes such as continence and erectile function.

      Professor Prasanna Sooriakumaran has been recognised among the leading prostate cancer surgeons in the UK, including being featured in the Daily Mail’s list of top prostate cancer surgeons. This recognition reflects both his experience and his commitment to delivering high-quality care for patients.

      This level of expertise is an important factor for patients seeking private prostate cancer treatment in London.

      Why Prostate Cancer Screening Matters

      Prostate cancer often develops without clear symptoms in its early stages. As a result, potential concerns may only become apparent through appropriate screening. Identifying issues at an earlier stage can allow for a wider range of management options and, in some cases, more favourable outcomes.

      Equally important, screening can provide reassurance where no significant concerns are identified. A structured, specialist-led approach helps to reduce uncertainty, avoid unnecessary anxiety, and ensure that further investigation is only recommended when it is truly needed.

      Who Should Consider Screening?

      Prostate cancer screening may be appropriate for men with specific risk factors or concerns about their prostate health. This can include those with a raised or rising PSA level, new urinary symptoms, or a family history of prostate cancer. Screening may also be considered as part of routine health assessment in men over the age of 50, or earlier in those at higher risk.

      In some cases, screening is sought for reassurance, even in the absence of symptoms. A structured assessment allows this to be approached in a considered and appropriate way.

      Each case is evaluated individually, taking into account your symptoms, risk factors, and overall health. This ensures that screening is only recommended where it is appropriate, and that the level of investigation is tailored to your specific situation.

      The Screening Pathway

      Prostate cancer screening follows a structured and carefully considered pathway designed to provide clarity while avoiding unnecessary tests or procedures. Rather than relying on a single result, each stage builds a more accurate understanding of your individual risk.

      This typically includes:

      • Initial consultation and PSA testing to assess baseline risk
      • Interpretation of results in clinical context, taking into account your age, symptoms, and medical history
      • MRI imaging where appropriate to provide detailed assessment of the prostate
      • Targeted next steps only if required, based on the findings

      This step-by-step approach ensures that decisions are based on accurate and relevant information, helping to reduce uncertainty while avoiding unnecessary investigation or intervention wherever possible.

      Understanding PSA and Your Results

      The PSA (prostate-specific antigen) blood test is often the first step in prostate cancer screening. However, PSA levels can vary between individuals and may be influenced by factors other than cancer, including benign prostate enlargement or inflammation.

      A raised PSA does not necessarily indicate prostate cancer. Results are interpreted in the context of your age, symptoms, medical history, and overall risk profile, rather than as a single isolated value.

      This allows for a more accurate and individualised assessment, helping to determine whether further investigation is needed while avoiding unnecessary tests where possible.

      What Happens If Further Investigation Is Needed?

      If screening identifies an area of concern, further assessment may be recommended to better understand the findings. This often includes an MRI scan, which provides detailed imaging of the prostate and helps guide the next steps.

      In some cases, a biopsy may be advised to confirm whether prostate cancer is present. This is only recommended where it is considered appropriate based on the results of your assessment.

      If prostate cancer is diagnosed, you will be provided with clear, specialist guidance on all suitable treatment options, tailored to your individual situation. This ensures that you have a full understanding of your diagnosis and can make an informed and confident decision about the next steps in your care.

      Why Specialist Assessment Matters

      Prostate cancer screening is not simply about performing tests, but about interpreting results accurately and deciding on the most appropriate next steps. This requires a detailed understanding of prostate disease, clinical context, and individual risk.

      Professor Prasanna Sooriakumaran provides a specialist, expert-led approach to screening, ensuring that significant findings are identified while unnecessary investigations are avoided. His focus is on delivering clarity, reducing uncertainty, and supporting informed, confident decision-making at every stage.

      Is Prostate Cancer Screening Right for You?

      Whether prostate cancer screening is appropriate depends on your individual risk factors, symptoms, and personal preferences.

      A consultation allows your situation to be assessed in full, with your PSA results, medical history, and any symptoms carefully considered. Clear, specialist guidance will be provided on whether screening is recommended, what it should involve, and whether any further investigation is required.

      This ensures that any decisions are based on your individual circumstances, allowing you to make an informed and confident choice about the next steps in your care.

      Book Your Consultation

      If you have concerns about prostate cancer, a raised PSA, or would like reassurance about your prostate health, a consultation with Professor Prasanna Sooriakumaran can provide clear, specialist guidance and a structured approach to screening.

      Book Your Consultation

      If you have concerns about prostate cancer, a raised PSA, or would like reassurance about your prostate health, a consultation with Professor Prasanna Sooriakumaran can provide clear, specialist guidance and a structured approach to screening.

      Frequently Asked Questions

      What is a normal PSA level?

      PSA levels vary depending on age and individual factors. Results are interpreted in context rather than relying on a single “normal” value.

      Does a raised PSA mean I have prostate cancer?

      No, a raised PSA does not necessarily mean prostate cancer is present. Other factors, such as prostate enlargement or inflammation, can also affect PSA levels.

      Will I need an MRI scan?

      In many cases, an MRI scan may be recommended if PSA levels are raised or if further evaluation is needed. This helps guide decisions and may reduce the need for unnecessary biopsy.

      Is prostate cancer screening recommended for everyone?

      Screening is not routinely recommended for all men but may be appropriate depending on age, risk factors, and individual preference.

      Why should I see a specialist for prostate cancer screening?

      A specialist can interpret results accurately, advise on the need for further investigation, and ensure that the most appropriate pathway is followed based on your individual situation.

      Professor Prasanna Sooriakumaran in the Media

      Professor Prasanna Sooriakumaran

      Professor Prasanna Sooriakumaran discusses the importance of being a patient-centred doctor and the value of cultivating emotional intelligence in patient interactions during this podcast.

      Professor Prasanna Sooriakumaran discusses men’s health, prostate cancer, and longevity medicine in the inaugural Emerald podcast.

      Professor Prasanna Sooriakumaran discusses whether you should consider prostate cancer screening.

      Professor Prasanna Sooriakumaran introduces himself to Top Doctors and discusses what he is most passionate about: caring for patients.

      Professor Prasanna Sooriakumaran was a guest on Nadia’s Lab, where he discussed prostate cancer, robotic surgery, and what every man should know about prostate health.

      Professor Prasanna Sooriakumaran gives an overview of all aspects of prostate cancer, from screening and diagnosis to treatment options and beyond.

      Leadership Roles

      Professor Prasanna Sooriakumaran is always looking to grow, innovate, and improve patient care for urology and prostate cancer patients in every possible way. To achieve this, he has secured several other prestigious leadership roles.

      Urological innovation

      Chief Men’s Health Officer

      Chief Academic Officer

      Lead Medical Advisor in Men’s Health

      Research Physician

      Lead for Urology and Men’s Health

      Clinical Lead for Robotic Soft-Tissue Surgery

      Invited Reviewer

      oxford
      nuffield department of surgical sciences

      Leading a £3 Million Prostate Cancer Surgery Trial at the University of Oxford

      Professor Prasanna Sooriakumaran is actively advancing the field of prostate cancer surgery through his academic and clinical research. He is leading a landmark prostate cancer surgery trial supported by a £3 million Department of Health and Social Care grant at the University of Oxford.

      This major research initiative is focused on improving surgical techniques and patient outcomes, reflecting a commitment not only to delivering high-quality care today, but also to shaping the future of prostate cancer treatment.

      Through his ongoing work in research and innovation, Professor Prasanna Sooriakumaran remains at the forefront of developments in prostate cancer surgery, ensuring patients benefit from the most advanced and evidence-based approaches available.

      Appointed to Establish Mayo Clinic’s Urology & Prostate Services in London

      Professor Prasanna Sooriakumaran has been appointed as the first urologist for the new London centre of Mayo Clinic, ranked the world’s best hospital by Newsweek and consistently recognised as one of the leading healthcare institutions globally. In this role, he is leading the development of Mayo Clinic’s Urology and Prostate Services in London, reflecting his internationally recognised expertise in prostate cancer surgery and advanced urological care.

      Patient Experiences

      Read all of Professor Prasanna Sooriakumaran’s patient reviews at Doctify.

      Consultation Locations

      Professor Prasanna Sooriakumaran practises as a robotic prostate cancer surgeon within the NHS at one of the UK’s highest-volume centres. He also sees private patients at leading private hospitals across London, providing access to high-quality facilities and specialist care.